From 13 to 15 of November, we are in Athens for the 2nd Symposium on Molecular Radiotherapy Dosimetry, organized by the EFOMP Special Interest Group for Radionuclide Internal Dosimetry and the Hellenic Association of Medical Physicists. This is a meeting dedicated to the science that quietly powers theranostics. With hands-on sessions, debates and discussions on the future of informed treatment planning, it’s a rare chance to explore how precision dosimetry continues to shape the evolution of molecular radiotherapy.
At BIOEMTECH, dosimetry is one of the ways of supporting the development of safe and effective RadioLigand Therapies. By combining in vivo imaging, ex vivo biodistribution and advanced software tools, our team provides robust absorbed-dose estimates, pharmacokinetic insights, and radiobiological modelling tailored to preclinical research needs.
From designing biodistribution studies to interpreting results through the lens of medical physics, we help researchers translate molecular radiotherapy concepts into reliable, clinically relevant data.